CDKN2A and metastatic melanoma: However, the crossing of these mice into Ink4a/Arf-null background demonstrated the importance of the cooperation of these mutations, since Tyr-NRASQ61K, Ink4a/Arf mice developed metastatic melanomas at higher penetrance (83%) and shorter latency, with lung and liver metastasis [33].